Correlation Between Virax Biolabs and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Neoleukin Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Neoleukin Therapeutics.
Diversification Opportunities for Virax Biolabs and Neoleukin Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Virax and Neoleukin is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Neoleukin Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 2.61 times more return on investment than Neoleukin Therapeutics. However, Virax Biolabs is 2.61 times more volatile than Neoleukin Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 410.00 in Virax Biolabs Group on August 31, 2024 and sell it today you would lose (213.00) from holding Virax Biolabs Group or give up 51.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 8.56% |
| Values | Daily Returns |
Virax Biolabs Group vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Virax Biolabs and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Neoleukin Therapeutics
The main advantage of trading using opposite Virax Biolabs and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |